New bicyclam–GalCer analogue conjugates: synthesis and in vitro anti-HIV activity
- 1 January 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (2) , 495-498
- https://doi.org/10.1016/j.bmcl.2003.10.036
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The therapeutic potential of CXCR4 antagonists in the treatment of HIVExpert Opinion on Investigational Drugs, 2003
- Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseasesExpert Reviews in Molecular Medicine, 2002
- New anti‐HIV agents and targetsMedicinal Research Reviews, 2002
- HIV-1 gp41 Envelope Residues 650–685 Exposed on Native Virus Act as a Lectin to Bind Epithelial Cell Galactosyl CeramideJournal of Biological Chemistry, 2002
- Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapyProgress in Lipid Research, 2001
- Lipid rafts and HIV-1: from viral entry to assembly of progeny virionsJournal of Clinical Virology, 2001
- Secretory IgA Specific for a Conserved Epitope on gp41 Envelope Glycoprotein Inhibits Epithelial Transcytosis of HIV-1The Journal of Immunology, 2001
- HIV fusion and its inhibitionAntiviral Research, 2001
- HIV-1 Membrane FusionThe Journal of cell biology, 2000
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999